Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1383 of 6351
-
New combo therapy for bile duct cancer enters safety trial
Disease control Recruiting nowThe goal of this clinical trial is to provide evidence for the general tolerability of radiofrequency ablation (bRFA) in patients with unresectable bile duct cancer undergoing systemic palliative treatment consisting of systemic anti-tumor therapy with or without immune-checkpoin…
Phase 2 • Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Could a diabetes pill protect kidneys in lupus patients?
Disease control Recruiting nowLupus nephritis is a chronic and life-threatening autoimmune cause of kidney disease that predominately impacts young people and can lead to kidney failure. Sodium-glucose co-transporter-2 inhibitors, including dapagliflozin, are known to improve outcomes for people with other ca…
Phase 4 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Could a common MS drug help stroke patients? new trial begins
Disease control Recruiting nowSpontaneous intracerebral haemorrhage (ICH) is a life-threatening condition, still devoided of specific treatment. Peri-haematomal oedema (PHO) develops in the ensuing days after ICH onset and worsens functional outcome. Hence, PHO is a promising therapeutic target but until now …
Phase 2 • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
New eye injection could reduce treatment frequency for wet AMD
Disease control Recruiting nowThis Phase 1b/2a study will primarily investigate the safety and tolerability of EYC-0305 delivered by intravitreal (IVT) injection every 24 weeks in patients with neovascular (wet) age-related macular degeneration (AMD). The pharmacokinetics (PK) and immunogenicity of EYC-0305, …
Phase 1/2 • Sponsor: Eyconis INC. • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Can filtering the blood slow ALS in people with a troubling antibody?
Disease control Recruiting now10-20% of patients with ALS have anti-NRIP autoantibody and the titer of anti-NRIP autoantibody is correlated with motor functional decline and mortality in ALS. The PALADIN2 clinical trial is a single arm study, which intends to enroll 20 ALS patients having anti-NRIP autoantibo…
Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Smart insulin pump could ease diabetes after pancreas surgery
Disease control Recruiting nowIndividuals with diabetes secondary to pancreatectomy experience impaired quality of life, partly due to the challenges of managing highly variable blood glucose levels. Hybrid closed-loop (HCL) automated insulin delivery (AID) systems, widely evaluated in type 1 diabetes, may im…
Sponsor: Centre Hospitalier Sud Francilien • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Nerve block shot could ease Long-COVID brain fog and fatigue?
Symptom relief Recruiting nowPost-COVID Condition (PCC) affects roughly 2.1 million Canadians, carrying an annual economic burden of CAD $7.8-50.6 billion. It presents across multiple organ systems with symptoms including fatigue, brain fog, palpitations, and orthostatic intolerance, at an annual cost of CAD…
Phase 4 • Sponsor: University Health Network, Toronto • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
New oral drug balinatunfib tested for long-term control of Crohn's and colitis
Disease control By invitation onlyLTS19689 is a multinational, multicenter extension study to evaluate the long-term safety, tolerability and efficacy of balinatunfib in participants with Crohn's disease (CD) or ulcerative colitis (UC) who completed the 52-week treatment period (on balinatunfib or placebo) in the…
Phase 2 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Could a simple talk therapy help struggling mothers in peru? new trial aims to find out
Disease control Recruiting nowRecent advances in intervention research have revealed the promise of transdiagnostic, modular approaches implemented by lay paraprofessionals for the treatment of the most prevalent mental health concerns in settings affected by adversity (e.g., anxiety, depression, posttraumati…
Phase 2 • Sponsor: University of Notre Dame • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Could a gas-busting ingredient in colonoscopy prep help spot more cancers?
Diagnosis Recruiting nowStudy to evaluate the efficacy and tolerability of a simethicone-containing evacuating solution for colorectal cancer screening colonoscopy.
Phase 4 • Sponsor: Fundacion Clinic per a la Recerca Biomédica • Aim: Diagnosis
Last updated Jul 12, 2026 00:00 UTC
-
A new tool to forecast tracheostomy healing time?
Knowledge-focused CompletedProlonged tracheostomy is prone to induce chronic airway mucosal injury and tracheal cartilage degeneration, which not only elevates the risks of post-decannulation complications such as persistent fistula non-healing, airway stenosis and recurrent infections, but also impairs ve…
Sponsor: Capital Medical University • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC
-
Ultrasound might reveal hidden lung damage in COPD
Knowledge-focused CompletedThis cross-sectional study aims to compare lung ultrasound findings, functional capacity, and dyspnea among patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD), patients with stable COPD, and healthy controls. The study will include approximately 60…
Sponsor: Hacettepe University • Aim: Knowledge-focused
Last updated Aug 13, 2026 00:00 UTC
-
Hunting for biological clues to long COVID's mysteries
Knowledge-focused Recruiting nowThe purpose of this study is to better understand the biological changes associated with Long COVID and to identify laboratory tests (biomarkers) that may help diagnose the condition and measure how it changes over time. Researchers will enroll people with Long COVID as well as p…
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Aug 20, 2026 00:00 UTC
-
New hope for rare lung disease: JAK inhibitors vs standard care
Disease control Recruiting nowThis study is a prospective investigation comparing the efficacy and safety of Janus kinase inhibitors versus calcineurin inhibitors as initial therapy for interstitial lung disease associated with antisynthetase syndrome. The goal is to determine which treatment is more effectiv…
Sponsor: China-Japan Friendship Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Hearing loss shield: new drug may protect ears during chemo
Symptom relief Recruiting nowThe purpose of this study is to assess the safety and effectiveness of a drug called Pedmark® sodium thiosulfate (STS) in reducing hearing impairment with standard of care cisplatin therapy. The safety and effectiveness of STS in reducing hearing loss has been well established in…
Phase 1/2 • Sponsor: University of Arizona • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New stem cell therapy aims to restore kidney function in early trial
Disease control Recruiting nowThe goal of this clinical trial is to learn whether a new regenerative treatment called AdiaVita, made from umbilical cord blood-derived stem cells and exosomes combined with glutathione, is safe and can help improve kidney function in adults with chronic kidney disease (CKD). In…
Phase 1 • Sponsor: Adia Med of Winter Park LLC • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Double-Drug attack on cholesterol: could two be better than one?
Disease control Recruiting nowThis study will evaluate the effectiveness and safety of combining two different types of PCSK9 inhibitors, inclisiran and alirocumab, in patients with high cardiovascular risk who are unable to tolerate statins. Lowering low-density lipoprotein cholesterol (LDL-C) is essential …
Phase 4 • Sponsor: University Medical Centre Ljubljana • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Digital lifeline: new online tool aims to ease mental health distress for young people stuck on waiting lists
Symptom relief Not yet recruitingThis study, run by Amsterdam UMC in the Netherlands, looks at whether an online mental health platform called ENYOY can help improve psychological distress in young people (16-25) who are waiting for mental health care. Young people in the Netherlands aged 16 to 25 can take part …
Sponsor: Academisch Medisch Centrum - Amsterdam UMC Research BV • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
Wire-Free heart scan could cut unnecessary stents in heart attack patients
Disease control Not yet recruitingAcute coronary syndromes (ACS) are frequently associated with multivessel coronary artery disease (CAD), and current guidelines recommend complete revascularization beyond the culprit lesion. Angiography-guided PCI is the standard approach, but anatomical assessment does not alwa…
Sponsor: University of Roma La Sapienza • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New device could catch colon cancers that stool tests miss
Diagnosis Recruiting nowThe goal of this clinical trial is to learn if the Gixam device effectively identifies persons with pre-cancer or cancer in the colon and rectum in adults aged 45-84 that are of average risk to develop colorectal cancer and have received a negative result on a Fecal Immunochemica…
Sponsor: Jubaan Ltd. • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC